Search Results - "Benanti, F"

Asymptotics for Capelli polynomials with involution by Benanti, F. S., Valenti, A.

“…Let be the free associative algebra with involution * over a field F of characteristic zero. We study the asymptotic behavior of the sequence of *-codimensions…”
Get full text

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study by Cabibbo, G., Petta, S., Calvaruso, V., Cacciola, I., Cannavò, M. R., Madonia, S., Distefano, M., Larocca, L., Prestileo, T., Tinè, F., Bertino, G., Giannitrapani, L., Benanti, F., Licata, A., Scalisi, I., Mazzola, G., Cartabellotta, F., Alessi, N., Barbàra, M., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V., Cammà, C., Craxì, A., Di Marco, V., Cammà, C., Calvaruso, V., Petta, S., Colletti, P., Mazzola, G., Licata, A., Giannitrapani, L., Corrao, S., Prestileo, T., Di Lorenzo, F., Fecarotta, R., Sanfilippo, P., Madonia, S., Tinè, F., Malizia, G., Latteri, F., Maida, M., Cartabellotta, F., Vassallo, R., Cacciola, I., Caccamo, G., Maimone, S., Saitta, C., Squadrito, G., Raimondo, G., Mondello, L., Smedile, A., Bertino, G., Ardiri, A.L., Montineri, A., Larocca, L. N., Cacopardo, B., Benanti, F., Russello, M., Benigno, R., Cannavò, M. R., Bellia, A., Iacobello, C., Davì, A., Di Rosolini, M. A., Digiacomo, A., Fuduli, G., Scifo, G., Distefano, M., Portelli, V., Savalli, F., Scalici, I., Gioia, G., Magro, A., Alaimo, G., Salvo, A., Averna, A., Lomonaco, F., Quattrocchi, U., Guarneri, L., Maffeo, F.

“…Summary Background Data on HCV‐related hepatocellular carcinoma (HCC) early recurrence in patients whose HCC was previously cured, and subsequently treated by…”
Get full text

Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily Registry by Cacciola, I, Petta, S, Di Stefano, M, Cannavò, M.R, Davì, A, Madonia, S, Calvaruso, V, Rocca, L.L, Di Lorenzo, F, Digiacomo, A, Bertino, G, Licata, A, Benanti, F, Volpes, R, Guarneri, L, Averna, A, Scalisi, I, Iacobello, C, Colletti, P, Cartabellotta, F, Portelli, V, Russello, M, Scifo, G, Squadrito, G, Raimondo, G, Craxì, A, Di Marco, V

Get full text

Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals by Cabibbo, G, Cacciola, I, Cannavò, M.R, Madonia, S, Calvaruso, V, Petta, S, Di Stefano, M, Larocca, L, Prestileo, T, Tinè, F, Digiacomo, A, Bertino, G, Giannitrapani, L, Benanti, F, Davì, A, Volpes, R, Guarneri, L, Averna, A, Scalisi, I, Iacobello, C, Mazzola, G, Cartabellotta, F, Portelli, V, Russello, M, Scifo, G, Squadrito, G, Raimondo, G, Craxì, A, Di Marco, V, Cammà, C

Get full text

Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry by Cacciola, I, Petta, S, Distefano, M, Cannavò, M.R, Davì, A, Madonia, S, Calvaruso, V, Larocca, L, Di Lorenzo, F, Digiacomo, A, Bertino, G, Licata, A, Latteri, F, Benanti, F, Volpes, R, Guarneri, L, Averna, A, Scalisi, I, Iacobello, C, Colletti, P, Cartabellotta, F, Portelli, V, Russello, M, Scifo, G, Squadrito, G, Raimondo, G, Craxì, A, Di Marco, V

Get full text

Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs) by Cabibbo, G, Cacciola, I, Cannavò, M.R, Madonia, S, Calvaruso, V, Petta, S, Distefano, M, Larocca, L, Prestileo, T, Tinè, F, Digiacomo, A, Bertino, G, Giannitrapani, L, Benanti, F, Davì, A, Volpes, R, Scalisi, I, Iacobello, C, Mazzola, G, Cartabellotta, F, Guarneri, L, Portelli, V, Averna, A, Russello, M, Scifo, G, Squadrito, G, Raimondo, G, Craxì, A, Di Marco, V, Cammà, C

Get full text

Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response by Pinzone, M R, Zanghì, A M, Rapisarda, L, D'Agata, V, Benanti, F, Spartà, D, Nunnari, G, Cacopardo, B

“…Hepatitis C virus (HCV) infection is a common cause of chronic liver disease and hepatocellular carcinoma (HCC). The prevalence of HCC significantly declines…”
Get more information

Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect by Nunnari, G, Celesia, B M, Bellissimo, F, Tosto, S, La Rocca, M, Giarratana, F, Benanti, F, Caltabiano, E, Russo, R, Cacopardo, B

“…To report hypoglycaemia, a life-threatening adverse event, associated with trimethoprim-sulfamethoxazole. A sulfonylurea-like effect, leading to insulin raise,…”
Get more information

Leukocyte Interferon Alpha Early Retreatment for Child A HCV Genotype 1b-Infected Cirrhotics Intolerant to Pegylated Interferons by Cacopardo, B, Nunnari, G, Benanti, F, Cappellani, A, Onorante, A, Caltabiano, E, Russo, R

“…Background and Aim: The pegylated interferon (PEG-IFN)/ribavirin combination has been shown to be effective for hepatitis C virus (HCV)-related compensated…”
Get full text

Minimal varieties of PI-algebras with graded involution by Benanti, F.S., Di Vincenzo, O.M., Valenti, A.

“…Let F be an algebraically closed field of characteristic zero and G a cyclic group of odd prime order. We consider the class of finite dimensional…”
Get full text

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents by Calvaruso, Vincenza, Cabibbo, Giuseppe, Cacciola, Irene, Petta, Salvatore, Madonia, Salvatore, Bellia, Alessandro, Tinè, Fabio, Distefano, Marco, Licata, Anna, Giannitrapani, Lydia, Prestileo, Tullio, Mazzola, Giovanni, Di Rosolini, Maria Antonietta, Larocca, Licia, Bertino, Gaetano, Digiacomo, Antonio, Benanti, Francesco, Guarneri, Luigi, Averna, Alfonso, Iacobello, Carmelo, Magro, Antonio, Scalisi, Ignazio, Cartabellotta, Fabio, Savalli, Francesca, Barbara, Marco, Davì, Antonio, Russello, Maurizio, Scifo, Gaetano, Squadrito, Giovanni, Cammà, Calogero, Raimondo, Giovanni, Craxì, Antonio, Di Marco, Vito, Craxì, A., Di Marco, V., Cammà, C., Calvaruso, V., Petta, S., Cabbibbo, G., Colletti, P., Mazzola, G., Cascio, A., Montalto, G., Licata, A., Giannitrapani, L., Prestileo, T., Di Lorenzo, F., Sanfilippo, A., Ficalora, A., Madonia, S., Tinè, F., Malizia, G., Latteri, F., Maida, M., Cartabellotta, F., Vassallo, R., Cacciola, I., Caccamo, G., Maimone, S., Saitta, C., Squadrito, G., Raimondo, G., Mondello, L., Smedile, A., D’Andrea, S., Bertino, G., Ardiri, A.L., Frazzetto, E., Rigano, G., Montineri, A., Larocca, L.N., Cacopardo, B., Benanti, F., Russello, M., Benigno, R., Bellia, A., Iacobello, C., Davì, A., Di Rosolini, M.A., Digiacomo, A., Fuduli, G., Scifo, G., Distefano, M., Portelli, V., Savalli, F., Scalici, I., Gioia, G., Magro, A., Alaimo, G., Alinovi, M.R., Salvo, A., Averna, A., Lomonaco, F., Guarneri, L., Maffeo, F., Falzone, E., Pulvirenti, F.

“…Studies have produced conflicting results of the incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C virus–associated cirrhosis treated…”
Get full text

Acute hepatitis E in Catania (eastern Sicily) 1980-1994: The role of hepatitis E virus by CACOPARDO, B, RUSSO, R, PREISER, W, BENANTI, F, BRANCATI, G, NUNNARI, A

“…Between 1980 and 1994, 540 patients with acute viral hepatitis were admitted to hospital at the Department of Infectious Diseases of Catania (eastern Sicily)…”
Get full text

Fatal hepatitis during Epstein-Barr virus reactivation by Cacopardo, B, Nunnari, G, Mughini, M T, Tosto, S, Benanti, F, Nigro, L

“…Fulminant hepatitis by Epstein-Barr virus is a rare event which is predominantly due to primary infection. We report a rare case of fatal hepatic failure due…”
Get full text

Leucocyte interferon-α retreatment for chronic hepatitis C patients previously intolerant to other interferons by Cacopardo, B., Benanti, F., Brancati, G., Romano, F., Nunnari, A.

“…The activity and tolerability of a retreatment cycle with leucocyte interferon‐α (IFN‐α) (6 million units (MU) three times weekly for 12 months) was evaluated…”
Get full text

Efficacy and safety of pangenotypic DAAs for chronic HCV infection: real-world data from the RESIST-HCV cohort by Salomone, F., Cacciola, I., Petta, S., Calvaruso, V., Micek, A., Madonia, S., Grova, M., Distefano, M., Cannavò, M., Di Rosolini, M.A., Digiacomo, A., Di Lorenzo, F., Bertino, G., Licata, A., Latteri, F., Benanti, F., Averna, A., Guarneri, L., Scalisi, I., Iacobello, C., Montineri, A., Colletti, P., Cartabellotta, F., Davì, A., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V.

Get full text

OC.07.1 DIRECT ACTING ANTIVIRALS AFTER SUCCESSFUL TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA IMPROVE SURVIVAL AND REDUCE HEPATIC DECOMPENSATION IN HCV-CIRRHOTIC PATIENTS by Celsa, C., Cabibbo, G., Calvaruso, V., Petta, S., Cacciola, I., Cannavò, M.R., Madonia, S., Rossi, M., Magro, B., Rini, F., Distefano, M., Larocca, L., Prestileo, T., Malizia, G., Bertino, G., Benanti, F., Licata, A., Scalisi, I., Mazzola, G., Di Rosolini, M.A., Alaimo, G., Averna, A., Cartabellotta, F., Alessi, N., Guastella, S., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V., Cammà, C.

Get full text

Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort by Cacciola, I., Petta, S., Calvaruso, V., Cartabellotta, F., Distefano, M., Scifo, G., Di Lorenzo, F., Sanfilippo, A., Di Rosolini, M.A., Davì, A., Benanti, F., Cacopardo, B., Licata, A., Giannitrapani, L., Cannavò, M.R., Russello, M., Madonia, S., Bavetta, M.G., Digiacomo, A., Averna, A., Alaimo, G., Larocca, L., Bertino, G., Bronte, F., Guarneri, L., Scalisi, I., Iacobello, C., Colletti, P., Portelli, V., Pollicino, T., Ceccherini-Silberstein, F., Raimondo, G., Craxì, A., Di Marco, V.

Get full text

Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients by Cabibbo, G., Celsa, C., Calvaruso, V., Petta, S., Cacciola, I., Cannavò, M.R., Madonia, S., Rossi, M., Magro, B., Rini, F., Distefano, M., Larocca, L., Prestileo, T., Malizia, G., Bertino, G., Benanti, F., Licata, A., Scalisi, I., Mazzola, G., Di Rosolini, M.A., Alaimo, G., Averna, A., Cartabellotta, F., Alessi, N., Guastella, S., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V., Cammà, C.

Get full text

FRI-228 - Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily Registry by Cacciola, I., Petta, S., Di Stefano, M., Cannavò, M.R., Davì, A., Madonia, S., Calvaruso, V., Rocca, L.L., Di Lorenzo, F., Digiacomo, A., Bertino, G., Licata, A., Benanti, F., Volpes, R., Guarneri, L., Averna, A., Scalisi, I., Iacobello, C., Colletti, P., Cartabellotta, F., Portelli, V., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V.

Get full text

THU-096 - Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals by Cabibbo, G., Cacciola, I., Cannavò, M.R., Madonia, S., Calvaruso, V., Petta, S., Di Stefano, M., Larocca, L., Prestileo, T., Tinè, F., Digiacomo, A., Bertino, G., Giannitrapani, L., Benanti, F., Davì, A., Volpes, R., Guarneri, L., Averna, A., Scalisi, I., Iacobello, C., Mazzola, G., Cartabellotta, F., Portelli, V., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V., Cammà, C.

Get full text